The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
H H S Department of Health and Human Services
Health Resources and Services Administration
HIV/AIDS Programs

A-Z Index  |  Questions? 

  • Print this
  • Email this

Part B: AIDS Drug Assistance Program

Part B of the Ryan White HIV/AIDS Treatment Extension Act of 2009 (Public Law 111-87) provides grants to States and U.S. territories. Part B grants include a base grant, the AIDS Drug Assistance Program (ADAP) base awards, ADAP supplemental funds, ADAP Emergency Relief grants, funding for Emerging Communities, and upon request, additional funds for Minority AIDS Initiative activities. Eligible grant recipients may also apply for Supplemental Part B funding. ADAPs provide FDA-approved prescription medications for eligible people living with HIV who have limited or no prescription drug coverage or who need assistance with insurance premiums and cost-sharing. ADAP funds are distributed by a formula based on living HIV/AIDS cases. ADAP Supplemental funds are a five percent set-aside for states with severe need that prevents them from providing medications consistent with Public Health Service guidelines.

ADAP funds also may be used to purchase health insurance for eligible clients or to pay for services that enhance access, adherence, and monitoring of drug treatments.

Grant Recipients

Grant recipients are state departments of health or other state governmental entities that implement and manage state public health programs. Grants are awarded to all 50 states, the District of Columbia, Puerto Rico, Guam, the U.S. Virgin Islands, and the six U.S. Pacific Territories or Associated Jurisdictions.

List of Part B FY 2015 grant recipients.

Funding Considerations

  • Congress designates a portion of the Ryan White HIV/AIDS Program Part B appropriation for the ADAP base. Other Part B spending decisions are made locally. 
  • A formula based on the number of reported living HIV/AIDS cases in the state or territory in the most recent calendar year is used to award ADAP funds

Client Eligibility

Client eligibility is determined by the state and territory and includes financial and medical eligibility criteria. Financial eligibility is usually determined as a percentage of the Federal Poverty Level. Medical eligibility is a diagnosis of HIV.

  • Clients must provide proof of current state residency.
  • ADAPs are required to recertify client eligibility every six months.

ADAP Implementation

Current legislation requires that each grant recipient must cover all classes of approved HIV antiretrovirals on their ADAP formulary. However, the ADAP in each state and territory decides which medications will be included in its formulary and how those medications will be distributed.

HRSA's HIV/AIDS Bureau continues to work to ensure that everyone who is eligible for ADAP is receiving medications. In addition, the HIV/AIDS Bureau works with its grant recipients to ensure clients, HIV service providers and affected communities are informed and educated on other means of accessing medications.

Part B - ADAP Resources

A Living History: Get the Back Story image.

Part B grew into the largest component of the Ryan White HIVAIDS Program primarily as a result of increases in funds to support access to drug therapies.

Part B - ADAP Publications

Technical Assistance TARGET Center Library Exit Disclaimer

Part B: States and U.S. Territories Program Fact Sheet (PDF - 221 KB)